ASCO 2019: What to watch for, including Keytruda, Lynparza, KRAS and more

31st May 2019 Uncategorised 0

As the year’s largest cancer confab, the American Society of Clinical Oncology annual meeting features more new data than any one person could hope to absorb—and more than we could hope to cover. We’re breaking down the highlights below to give you a glimpse at the top studies we’re tracking, so you can follow along, too.

More: ASCO 2019: What to watch for, including Keytruda, Lynparza, KRAS and more
Source: fierce